HAE
Price
$83.61
Change
+$2.37 (+2.92%)
Updated
Apr 22, 6:59 PM EST
16 days until earnings call
TCMD
Price
$14.65
Change
+$0.25 (+1.74%)
Updated
Apr 22, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare predictions HAE vs TCMD

Header iconHAE vs TCMD Comparison
Open Charts HAE vs TCMDBanner chart's image
Haemonetics
Price$83.61
Change+$2.37 (+2.92%)
Volume$145.79K
CapitalizationN/A
Tactile Systems Technology
Price$14.65
Change+$0.25 (+1.74%)
Volume$53.36K
CapitalizationN/A
View a ticker or compare two or three
HAE vs TCMD Comparison Chart

Loading...

HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HAE vs. TCMD commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and TCMD is a Hold.

COMPARISON
Comparison
Apr 23, 2024
Stock price -- (HAE: $83.62 vs. TCMD: $14.65)
Brand notoriety: HAE and TCMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 90% vs. TCMD: 36%
Market capitalization -- HAE: $4.33B vs. TCMD: $369.35M
HAE [@Medical Specialties] is valued at $4.33B. TCMD’s [@Medical Specialties] market capitalization is $369.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileTCMD’s FA Score has 0 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • TCMD’s FA Score: 0 green, 5 red.
According to our system of comparison, TCMD is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 6 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).

  • HAE’s TA Score: 6 bullish, 4 bearish.
  • TCMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HAE is a better buy in the short-term than TCMD.

Price Growth

HAE (@Medical Specialties) experienced а -1.48% price change this week, while TCMD (@Medical Specialties) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.30%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +13.32%.

Reported Earning Dates

HAE is expected to report earnings on Aug 06, 2024.

TCMD is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Medical Specialties (-0.30% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for HAE with price predictions.
OPEN
A.I.dvisor published
a Summary for TCMD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than TCMD($369M). HAE has higher P/E ratio than TCMD: HAE (34.47) vs TCMD (12.72). TCMD YTD gains are higher at: 2.448 vs. HAE (-2.210). HAE has higher annual earnings (EBITDA): 264M vs. TCMD (24.5M). HAE has more cash in the bank: 194M vs. TCMD (75.2M). TCMD has less debt than HAE: TCMD (50.4M) vs HAE (871M). HAE has higher revenues than TCMD: HAE (1.27B) vs TCMD (274M).
HAETCMDHAE / TCMD
Capitalization4.34B369M1,175%
EBITDA264M24.5M1,078%
Gain YTD-2.2102.448-90%
P/E Ratio34.4712.72271%
Revenue1.27B274M464%
Total Cash194M75.2M258%
Total Debt871M50.4M1,728%
FUNDAMENTALS RATINGS
HAE vs TCMD: Fundamental Ratings
HAE
TCMD
OUTLOOK RATING
1..100
6167
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5950
PRICE GROWTH RATING
1..100
5857
P/E GROWTH RATING
1..100
80100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCMD's Valuation (61) in the Medical Specialties industry is in the same range as HAE (76). This means that TCMD’s stock grew similarly to HAE’s over the last 12 months.

TCMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as HAE (100). This means that TCMD’s stock grew similarly to HAE’s over the last 12 months.

TCMD's SMR Rating (50) in the Medical Specialties industry is in the same range as HAE (59). This means that TCMD’s stock grew similarly to HAE’s over the last 12 months.

TCMD's Price Growth Rating (57) in the Medical Specialties industry is in the same range as HAE (58). This means that TCMD’s stock grew similarly to HAE’s over the last 12 months.

HAE's P/E Growth Rating (80) in the Medical Specialties industry is in the same range as TCMD (100). This means that HAE’s stock grew similarly to TCMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAETCMD
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 27 days ago
67%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDSCX30.210.32
+1.07%
JPMorgan Small Cap Blend I
CRSSX9.120.08
+0.88%
Catholic Rspnsbl Invstmnts Small-Cap Ins
BOSCX17.790.14
+0.79%
BNY Mellon Sm Cp Val C
HMDYX34.260.17
+0.50%
Hartford MidCap Y
FHEJX3.93N/A
N/A
Delaware Hedged U.S. Equity Opps A

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with LIVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+2.93%
LIVN - HAE
42%
Loosely correlated
+3.21%
INSP - HAE
41%
Loosely correlated
-1.75%
STE - HAE
39%
Loosely correlated
+0.70%
VCYT - HAE
37%
Loosely correlated
+2.06%
GMED - HAE
36%
Loosely correlated
+1.79%
More

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with ICUI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
+1.74%
ICUI - TCMD
57%
Loosely correlated
+0.64%
SWAV - TCMD
46%
Loosely correlated
-0.12%
AXGN - TCMD
43%
Loosely correlated
+5.54%
BNGO - TCMD
39%
Loosely correlated
+1.41%
TFX - TCMD
38%
Loosely correlated
+0.34%
More